Comparative Effects of Acute or Chronic Administration of Levodopa to 6-OHDA-lesioned Rats on the Expression and Phosphorylation of N-methyl-d-aspartate Receptor NR1 Subunits in the Striatum
- 109 Downloads
N-methyl-d-aspartate receptor (NMDA) has been increasingly implicated in the formation and maintenance of various forms of behavioral and synaptic plasticity. Recent evidence has linked striatal NMDA function to the adverse effects of long-term dopaminergic treatment in Parkinson’s disease. The subcellular distribution and phosphorylation of NMDA subunit, NR1, reflects NMDA receptor activity. To elucidate molecular mechanisms that underlie the persisting alterations in motor response occurring with levodopa treatment of parkinsonian patients, we evaluated the effects of unilateral nigrostriatal depletion with 6-hydroxydopamine and subsequent levodopa treatment on motor responses and NR1 alterations. Three weeks of levodopa administration to rats shortened the rotational duration and increased the peak turning responses, which lasted after withdrawal of chronic levodopa treatment. We found a significant reduction in the abundance of both phosphorylated NR1 on serine residues 890 and 896 (pNR1S890 and pNR1S896) and NR1 in the cell plasma membrane of lesioned striatum. Chronic treatment of lesioned rats with levodopa markedly upregulated pNR1S890, pNR1S896, and pNR1S897 in lesioned striatum with a concomitant normalization of the plasma membrane NR1 abundance. The magnitude of increased pNR1S890, pNR1S896, and pNR1S897 is dependent on the number of levodopa injections and is paralleled by a sensitization of the rotational response. Our data indicate that glutamate signaling is triggered during the levodopa administration. Activated NMDA receptor NR1-mediated mechanisms are involved in the persistent expression of the motor response alterations that appear during chronic levodopa therapy of parkinsonian rats and continue after treatment withdrawal.
KeywordsNR1 Phosphorylation Withdrawal Levodopa PD
This study was supported by the Project Sponsored by the Shanghai Pujiang Program, Shanghai-Philips Research and Development Funds, Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry and the Post-Project of Excellent Young Medical Person of Xihhua Hospital of Shanghai, China.
- 3.Chase TN, Oh JD (2000) Striatal mechanisms and pathogenesis of Parkinsonian signs and motor complications. Ann Neurol 47:S122–S129. doi: 10.1002/1531-8249(200001)47:1<122::AID-ANA21>3.0.CO;2-9 PubMedCrossRefGoogle Scholar
- 6.Calon F, Morissette M, Ghribi O et al (2002) Alteration of glutamate receptors in the striatum of dyskinetic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridinetreated monkeys following dopamine agonist treatment. Prog Neuropsychopharmacol Biol Psychiatry 26:127–138. doi: 10.1016/S0278-5846(01)00237-8 PubMedCrossRefGoogle Scholar
- 16.Tingley WG, Ehlers MD, Kameyama K et al (1997) Characterization of protein kinase A and protein kinase C phosphorylation of the N-methyl-d-aspartate receptor NR1 subunit using phosphorylation site-specific antibodies. J Biol Chem 272:5157–5166. doi: 10.1074/jbc.272.8.5157 PubMedCrossRefGoogle Scholar
- 20.Paxinos G, Watson C (1998) The rat brain in stereotaxic coordinates, 4th edn. Academic Press, LondonGoogle Scholar
- 23.Greenamyre JT (2000) New targets for therapy in Parkinson’s disease: pathogenesis and pathophysiology. Neurol (Tokyo) 15:67–80Google Scholar
- 26.Liste I, Munoz A, Guerra MJ et al (2000) Fenfluramineinduced increase in preproenkephalin mRNA levels in the striatum: interaction between the serotonergic, glutamatergic, and dopaminergic systems. Synapse 35:182–191. doi: 10.1002/(SICI)1098-2396(20000301)35:3<182::AID-SYN3>3.0.CO;2-T PubMedCrossRefGoogle Scholar
- 30.Calon F, Grondin R, Morissette M et al (2000) Molecular basis of levodopa-induced dyskinesias. Ann Neurol 47:70–78Google Scholar